Diabetes mellitus in Bardet Biedl syndrome

Curr Opin Endocrinol Diabetes Obes. 2023 Feb 1;30(1):27-31. doi: 10.1097/MED.0000000000000788. Epub 2022 Dec 8.

Abstract

Purpose of review: Bardet Biedl syndrome (BBS) is a rare disease characterized by obesity and hyperphagia. Despite the very high prevalence of paediatric and adult obesity in this population, the prevalence of diabetes mellitus is not well described.

Recent findings: Studies in small and moderately large cohorts suggest a high prevalence of traditional risk factors for diabetes mellitus in people with BBS. People with BBS appear to have a high prevalence of insulin resistance and metabolic syndrome. Small cohort studies have identified high rates of sleep disordered breathing, including sleep apnoea syndrome. Recent research has characterized traditional behavioural risk factors such as sleep hygiene and physical inactivity in people with BBS. High rates of insufficient sleep and prolonged sedentary time suggest behavioural targets of interventions to treat or prevent diabetes mellitus. Hyperphagia, likely caused by defects in the hypothalamic melanocortin-4 receptor (MC4R) neuronal pathway, pose additional challenges to behavioural interventions to prevent diabetes mellitus.

Summary: Understanding the prevalence of diabetes mellitus and other metabolic disorders in people with BBS and the impact of traditional risk factors on glucose regulation are important to developing effective treatments in this population.

Publication types

  • Review

MeSH terms

  • Adult
  • Bardet-Biedl Syndrome* / complications
  • Bardet-Biedl Syndrome* / epidemiology
  • Bardet-Biedl Syndrome* / metabolism
  • Child
  • Diabetes Mellitus* / epidemiology
  • Humans
  • Hyperphagia / complications
  • Metabolic Syndrome* / complications
  • Metabolic Syndrome* / epidemiology
  • Obesity / complications
  • Obesity / epidemiology